Duan-Shu Li

827 total citations
13 papers, 646 citations indexed

About

Duan-Shu Li is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Duan-Shu Li has authored 13 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Duan-Shu Li's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and RNA modifications and cancer (2 papers). Duan-Shu Li is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and RNA modifications and cancer (2 papers). Duan-Shu Li collaborates with scholars based in China. Duan-Shu Li's co-authors include Qinghai Ji, Yongxue Zhu, Qiang Shen, Wen‐Jun Wei, Yi‐Long Wu, Yu Wang, Ling Zhang, Caiping Huang, Ning Qu and Rong-Liang Shi and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Letters.

In The Last Decade

Duan-Shu Li

13 papers receiving 639 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Duan-Shu Li 395 277 210 145 70 13 646
Xiabin Lan 256 0.6× 142 0.5× 355 1.7× 325 2.2× 25 0.4× 28 627
Ruichao Zeng 233 0.6× 142 0.5× 134 0.6× 73 0.5× 26 0.4× 12 364
Quan-Yang Duh 335 0.8× 137 0.5× 183 0.9× 76 0.5× 92 1.3× 9 517
Rong-Liang Shi 191 0.5× 95 0.3× 145 0.7× 107 0.7× 28 0.4× 15 384
Inés Castro 379 1.0× 97 0.4× 167 0.8× 47 0.3× 98 1.4× 16 558
Fernando Rodrigues 279 0.7× 143 0.5× 112 0.5× 53 0.4× 72 1.0× 41 437
Vera Tiedje 338 0.9× 67 0.2× 125 0.6× 52 0.4× 85 1.2× 24 511
Lyndal Tacon 161 0.4× 160 0.6× 187 0.9× 230 1.6× 46 0.7× 17 416
Sam Q. Sun 115 0.3× 124 0.4× 112 0.5× 75 0.5× 42 0.6× 11 486
Eliška Václavíková 492 1.2× 200 0.7× 143 0.7× 75 0.5× 152 2.2× 33 653

Countries citing papers authored by Duan-Shu Li

Since Specialization
Citations

This map shows the geographic impact of Duan-Shu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duan-Shu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duan-Shu Li more than expected).

Fields of papers citing papers by Duan-Shu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duan-Shu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duan-Shu Li. The network helps show where Duan-Shu Li may publish in the future.

Co-authorship network of co-authors of Duan-Shu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Duan-Shu Li. A scholar is included among the top collaborators of Duan-Shu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duan-Shu Li. Duan-Shu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liao, Tian, Wen‐Jun Wei, Duo Wen, et al.. (2018). Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway. Journal of Cancer. 9(8). 1329–1336. 12 indexed citations
2.
Liao, Tian, Yu Wang, Ben Ma, et al.. (2018). Histone methyltransferase KMT5A gene modulates oncogenesis and lipid metabolism of papillary thyroid cancer in�vitro. Oncology Reports. 39(5). 2185–2192. 40 indexed citations
3.
Liao, Tian, Ning Qu, Rong-Liang Shi, et al.. (2016). BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Oncotarget. 8(1). 238–247. 68 indexed citations
4.
Qu, Ning, Rong-Liang Shi, Yulong Wang, et al.. (2016). Prognostic significance and optimal cutoff of age in medullary thyroid cancer. Oncotarget. 7(13). 15937–15947. 18 indexed citations
5.
Liao, Tian, Duo Wen, Ben Ma, et al.. (2016). Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway. Oncotarget. 8(7). 11719–11728. 28 indexed citations
6.
Qu, Ning, Rong-Liang Shi, Tian Liao, et al.. (2016). Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis. Oncotarget. 7(40). 65937–65945. 23 indexed citations
7.
Xiang, Jun, et al.. (2015). miR-584 Suppresses Invasion and Cell Migration of Thyroid Carcinoma by Regulating the Target Oncogene <b><i>ROCK1</i></b>. Oncology Research and Treatment. 38(9). 436–440. 37 indexed citations
8.
Wei, Wen‐Jun, Yulong Wang, Duan-Shu Li, et al.. (2014). Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population. Endocrine. 49(2). 436–444. 19 indexed citations
9.
Qu, Ning, Ling Zhang, Qinghai Ji, et al.. (2014). Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer. 14(1). 914–914. 64 indexed citations
10.
Wang, Yulong, Ji Zhu, Duan-Shu Li, et al.. (2013). Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis. PLoS ONE. 8(2). e56613–e56613. 36 indexed citations
11.
Wang, Yulong, Shicheng Guo, Wen‐Jun Wei, et al.. (2013). Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. Journal of Medical Genetics. 50(10). 689–695. 59 indexed citations
12.
Zhang, Ling, Wen‐Jun Wei, Qinghai Ji, et al.. (2012). Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Microcarcinoma: A Study of 1066 Patients. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1250–1257. 226 indexed citations
13.
Wang, Yulong, Jiu-Cun Wang, Yi‐Long Wu, et al.. (2008). Incidentally simultaneous occurrence of RET/PTC, H4–PTEN and BRAF mutation in papillary thyroid carcinoma. Cancer Letters. 263(1). 44–52. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026